Abstract 1 4
The telomerase reverse transcriptase (TERT) gene is responsible for telomere maintenance in 1 5 germline and stem cells, and is re-expressed in 90% of human cancers. Contrary to common 1 6 concepts, CpG methylation in the TERT promoter (TERTp), was correlated with TERT mRNA 1 7 expression. Furthermore, two hotspot mutations in TERTp, dubbed C228T and C250T, have been 1 8 revealed to assist binding of transcription factor ETS/TCF and subsequent TERT expression. This 1 9 study aimed to elucidate the combined contribution of epigenetic (promoter methylation and 2 0 higher-order chromatin structure) and genetic (promoter mutations) mechanisms in regulating 2 1 TERT gene expression in healthy skin and in melanoma cell lines (n=61). We unexpectedly 2 2 observed that the methylation of TERTp was as high in a subset of healthy skin cells, mainly 2 3 keratinocytes, as in cutaneous melanoma cell lines. In spite of the high promoter methylation 2 4 fraction in wild-type (WT) samples, TERT mRNA was only expressed in the melanoma cell lines 2 5
with high methylation or intermediate methylation in combination with TERT mutations. TERTp 2 6 methylation was positively correlated with chromatin accessibility and expression in 8 melanoma 2 7 cell lines. Cooperation between epigenetic and genetic mechanisms were best observed in 2 8 heterozygous mutant cell lines as chromosome accessibility preferentially concerned the mutant 2 9 allele. Combined, these results suggest a complex model in which TERT expression requires 3 0
either a widely open chromatin state throughout the promoter in TERTp-WT samples due to high 3 1 methylation or a combination of moderate methylation fraction/chromatin accessibility in the respectively (Fig 2) . Castelo-Branco et al. showed that methylation of the cg11625005 in TERTp, 1 0 1 was associated with tumour progression and poor prognosis of childhood brain tumours [20] . 1 0 2
Barthel et al. affirmed a correlation between methylation and TERT expression in samples 1 0 3 lacking somatic TERT alterations and a lower methylation level in normal samples [3] . Indeed, in 1 0 4 our study, the MF of fibroblasts was as low as that of the unmethylated control DNA, whereas 1 0 5 that of the keratinocytes was higher than most of the cutaneous melanoma cell lines ( Fig 2B) . The 1 0 6 MF of cg11625005 (position 1,295,737) obtained through NGS and by ddPCR were highly 1 0 7 correlated (R 2 =0.8166, P < 0.001) ( Fig 2C) . The MF of 1,295,731 assessed through ddPCR even 1 0 8 yielded a stronger correlation (R 2 =0.9580, P < 0.001) ( Fig 2D) . 1 0 9
Absence of correlation between methylation fraction and TERT expression
Cancer cells are commonly characterised by hypermethylation of promoter CpG islands resulting 1 1 1 in repression of tumour suppressor genes. However, in TERT, promoter hypermethylation was 1 1 2 found to be associated with higher expression, since CTCF repressors of TERT transcription do 1 1 3 not bind methylated sequences [3, 16, 17, 19] . In our sample cohort, there was no correlation 1 1 4 between TERT methylation of cg11625005 and mRNA expression (n=34, Fig 3 and an overview 1 1 5 in Fig 7C) . 1 1 6 Besides promoter methylation, somatic mutations are also known to be correlated with TERTp 1 1 8 reactivation. Therefore, we characterised the TERTp mutational status of the sample cohort. 1 1 9
Evaluation of TERTp mutations in a collection of skin samples and melanoma cell lines
Sanger sequencing on one naevus, fresh skin and cutaneous melanoma cell lines 518A2, 607B, 1 2 0 A375, 94.07 and 93.08 revealed melanoma-associated TERT C250T and C228T mutations ( Fig  1  2  1 4A). Aiming to use the ddPCR method to evaluate the mutational load of the samples, the TERT 1 2 2 C250T and C228T mutation assays were validated in three samples of which the mutation was 1 2 3 identified in sequencing analysis, 518A2, 607B and A375 ( Fig 4B) . Following the test runs, the 1 2 4
C228T and C250T assays were used on the extended sample cohort (n=61) (S5 Table and 94.13 cutaneous cell lines tested wild-type. The C250T mutation was not present in combination 1 2 7 with the C228T mutation in any sample, confirming that the mutations are mutually exclusive. 1 2 8
Absence of correlation between mutational status and TERT expression
As the presence of mutations in the gene promoter induces TERT reactivation, we assessed the 1 3 0 correlation between mutational status with TERT mRNA expression (n=34). When WT and 1 3 1 mutated samples (either C228T or C250T) were compared, regardless of origin of the tissue, no 1 3 2 significant differences for TERT mRNA expression were found ( Fig 5) . Moreover, TERT 1 3 3 expression was exclusive to the melanoma cell lines, either with or without TERTp mutations ( In contrast to most genes, methylation of the TERTp positively correlates with its mRNA 1 3 7 expression [3, 16, 17, 19 ]. Although we were not able to confirm this finding, we investigated 1 3 8
whether besides promoter methylation, other mechanisms could contribute to chromatin 1 3 9 accessibility to transcription factors affecting TERTp regulation. Therefore, we analysed 1 4 0 chromatin state in a subset of melanoma cell lines (cutaneous, 518A2, 607B, 94.07, A375, 93.08 Table) . When comparing the accessibility around cg11625005 to the methylation fraction of this 1 4 7
CpG, a significant positive correlation was observed (R 2 = 0.89, P<0.001) ( Fig 6B) . Another 1 4 8 positive correlation (R 2 =0.59, P<0.05) was found when comparing the accessibility of the same 1 4 9 region to the normalised TERT mRNA expression levels in these samples ( Fig 6C) . In actuality, 1 5 0 in this subset of 8 cell lines, the TERTp methylation and gene expression show a statistically 1 5 1 significant (P-value<0.05) positive correlation ( Fig 6D) . The 3 cell lines with higher MF are those 1 5 2 with the highest chromatin accessibility (OMM2.5, Mel270 and OCM8). Remarkably, these are 1 5 3 also the cell lines with WT-TERTp, in which the chromatin accessibility was significantly higher 1 5 4 than in the mutated subgroup ( Fig 6E) . 1 5 5
In addition, we investigated whether the TERT accessibility originated from the mutant or the 1 5 6 wildtype allele. For this purpose, we assessed the fractional abundance of mutated allele, in the 1 5 7 subgroup of 4 TERTp-mutated cutaneous cell lines before and after nuclease digestion. 607B cell 1 5 8 line was not included since it is homozygous for the mutation and not informative. Assuming that 1 5 9 the nuclease digests DNA in open and accessible chromatin regions, the observed decrease in 1 6 0 mutation fractional abundance after digestion ( Fig 6F) in all 4 cell lines suggest that mutated 1 6 1 alleles were preferably digested over WT alleles. 1 6 2 Discussion 1 6 3
By using advanced quantification methods, we investigated the epigenetic and genetic regulation 1 6 4
of TERTp in benign and malignant skin cells. Innovative ddPCR-based assays were developed 1 6 5 and validated to assess TERT promoter methylation and chromatin accessibility. These methods 1 6 6 overcome fallible bisulfite-conversion and avoid semi-quantitative qPCR and provide absolute 1 6 7 quantification even in samples that are challenged by DNA concentration and integrity. 1 6 8
The methylation fraction assessed by both NGS and ddPCR was high in a variety of normal 1 6 9 samples, of which mainly keratinocytes exceeded levels of cutaneous melanoma cell lines. This is 1 7 0 in contrast with previous investigations on brain tumours and skin melanoma that observed a 1 7 1 general absence of cg11625005 methylation in normal cells [3, 20] . In our study, methylation of 1 7 2 cg11625005 at position 1,295,737 did not stand out across the CpGs in TERTp but seemed to be 1 7 3 affected along with other CpG's in the surrounding region in all samples ( Fig 7B) . This result 1 7 4
suggests that context-related methylation around cg11625005 is biologically relevant in 1 7 5 opposition to methylation of one specific CpG. Consistent with previous findings, the 1 7 6 methylation of most samples gradually increased in the 5' direction and decreased near the 1 7 7 transcription start site (TSS) of the TERT gene ( Fig 7B) [19, 25] . Regardless of the methylation 1 7 8 status, human-derived benign cells did not express TERT indicating that other epigenetic 1 7 9 mechanisms are involved (Fig 8) . In contrast, analysis of tumour cell lines revealed a wide variety 1 8 0 of promoter methylation levels (5%-100% MF). TERT expression was found in all tumour cell 1 8 1 lines with or without TERTp mutation. 1 8 2 A plethora of histone modifications result in chromatin remodelling that may change accessibility 1 8 3 of the TERTp to transcription factors, such as ETS/TCF [7] . Therefore, we explored the higher-1 8 4 order chromatin state and its interaction with methylation levels and mRNA expression in 6 1 8 5 cutaneous and 2 uveal melanoma cell lines. We found that the gene accessibility around 1 8 6 cg11625005 showed a positive correlation with the methylation and TERT mRNA expression in 1 8 7 these samples. 1 8 8
We next investigated whether both wildtype and mutant TERT alleles were equally affected 1 8 9 by higher order chromatin organization and assessed the mutational fraction upon digestion 1 9 0 with nuclease, assuming that the nuclease only digests DNA in open and accessible 1 9 1 chromatin regions. We could infer that, mutated alleles are more accessible, possibly favouring 1 9 2 the binding of transcription factors, such as ETS/TCF, and consequently TERT expression of the 1 9 3 mutant allele (Fig 8) . The 94.07 cell line is an exception to the rule that still supports the 1 9 4 dominant role of higher order chromatin organization since both alleles were equally resistant to 1 9 5 nuclease digestion and presented with very low methylation fraction, explaining the lowest TERT 1 9 6 expression levels among all cell lines. Our results are in line with the study from Stern et al. and 1 9 7
Huang et al., where the authors found that active mutant allele allows monoallelic TERT 1 9 8 expression [25, 26] . 1 9 9
Another remarkable observation in our study is that in WT TERT-expressing uveal melanoma cell 2 0 0 lines, the methylation of the whole region surrounding cg11625005 is close to 100% with a 2 0 1 significantly higher chromatin accessibility compared to TERTp-mutated cell lines with moderate 2 0 2 methylation. In these cases, of TERTp-WT samples that show gene expression, we were not only 2 0 3 able to confirm but also expand previous results, in which TERTp methylation carries out a non-2 0 4 canonical role, leading to transcriptional activation (Fig 8) . 2 0 5
We conclude that ddPCR is a highly sensitive and quantifiable technique that can reliably assess 2 0 6 methylation fractions and mutational status even in CG-rich sequences such as TERT gene. 2 0 7
Further investigation in primary melanoma is needed to assess whether TERT methylation is 2 0 8 predictive of worse prognosis and at which methylation fraction this phenomenon occurs [25] . 2 0 9
Thereafter, quantification of TERT methylation might be used for the assessment of patient 2 1 0 prognosis, as it is readily applicable in the clinic. Although TERT is one of the most affected 2 1 1 1 0 genes in cancer, with its noncoding mutations cooperating with promoter methylation, further 2 1 2 investigation must be conducted to fully understand all epigenetic mechanisms that collectively 2 1 3 reactivate TERT. 2 1 4 Tissue samples were derived from anonymous patients and consisted of 11 normal skin samples, 2 1 7 6 frozen naevi, and low-passage cultured samples: 5 fibroblasts, 6 melanocytes and 8 2 1 8 keratinocytes. Primary human fibroblasts and keratinocytes were isolated from surplus human 2 1 9 breast skin as described before [27] . Keratinocytes were used at passage 2, while fibroblasts were 2 2 0 used at passage 3-5. The low-passage cultured fibroblasts, keratinocytes and melanocytes were a 2 2 1 kind gift from A. El Ghalbzouri and JJ Out-Luiting [27] . 2 2 2
Material and Methods
We also included 19 cutaneous and 6 uveal melanoma cell lines [28] . The batch thus consisted of 2 2 3 39 primary skin type samples and 25 melanoma cell lines, totalling 61 samples (Table 1) . The 2 2 4 study was approved by the Leiden University Medical Center institutional ethical committee (05-2 2 5 036) and was conducted according to the Declaration of Helsinki Principles. 2 2 6 
